Overview of the Global Infectious Respiratory Disease Diagnostics Industry:
The Global Infectious Respiratory Disease Diagnostics market is projected to experience substantial growth between 2023 and 2028, driven by digital transformation, innovation in service delivery, and expanding global demand. With a forecasted CAGR during the forecast period, i.e., 2023-28.
This report offers an in-depth analysis of the key drivers, challenges, competitive landscape, and future outlook — helping businesses, investors, and stakeholders make informed decisions.
Market Size & Forecast (2023–2028)
- Base Year: 2022
- Forecast Period: 2023-28
- Estimated CAGR (2023-28):
Key Market Driver (What’s Driving Infectious Respiratory Disease Diagnostics Sector Growth?)
The rise in the frequency of Respiratory Infectious Diseases drives Market Growth - The increasing geriatric population, the growing adoption of advanced molecular techniques due to The growing prevalence of respiratory diseases such as RSV, influenza, tuberculosis, etc., and government initiatives taken to reduce infectious disease incidents, drive the Market size. As per the analysis of the United States, around 4.2 million people are affected by pneumonia every year. To improve production to fulfill the surging demand in diagnostics for diagnosis of infectious respiratory diseases, some manufacturers are producing innovative techniques. For instance, in 2021, an InstaSwab utilizing 3D printing was introduced to meet the supply shortage of sample collection kits due to the COVID-19 pandemic.
In case you missed it, we are currently revising our reports. Click on the "request sample report" button to get the latest research data with forecast for the years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn't take long for the team to deliver the most recent version of the report.
("Engage with our team using your official business email to unlock full access and priority support.")
Request Free Sample Report: https://www.marknteladvisors.com/query/request-sample/infectious-respiratory-disease-diagnostics-market.html
Top Companies in the Infectious Respiratory Disease Diagnostics Market
Here’s a snapshot of key players leading innovation and market share:
- Abacus Diagnostica Oy
- Abbott Laboratories
- Agilent Technologies, Inc.
- Becton, Dickinson and Company (BD)
- Biocartis
- bioMérieux SA
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Hoffmann-La Roche AG
- Koninklijke Philips N.V.
- Illumina, Inc.
- QIAGEN N.V.
- Siemens Healthcare GmbH
- Thermo Fisher Scientific Inc.
- PerkinElmer, Inc.
- Hologic Inc.
- Novacyt Group
- Qiagen
- Quidel Corporation
- Seegene, Inc.
- SDI Diagnostics
The market is highly fragmented, with a mix of global and regional players competing for market share. To Learn More About the Global Trends Impacting the Future of Top 10 Companies in Premium Infectious Respiratory Disease Diagnostics Market
Explore Our Comprehensive Study: https://www.marknteladvisors.com/research-library/infectious-respiratory-disease-diagnostics-market.html
Infectious Respiratory Disease Diagnostics Market Segmentation Analysis
-By Product Type
- Instruments
- Consumables
- Services
Of these three, consumables dominated the Global Infectious Respiratory Disease Diagnostics Market.
-By Sample Type
- Nasopharyngeal Swabs (NPS)
- Anterior Nasal Region
- Blood
- Saliva
Here, Nasopharyngeal Swabs (NPS) dominated the market with the largest share in the previous years.
-By Application
- Covid-19
- Influenza
- RSV (Respiratory Syncytial Virus)
- Tuberculosis
- Streptococcus Testing
- Others
-By Technology
- Immunoassay
- Molecular Diagnostics
- Microbiology
- Others
-By End-User
- Hospitals
- Diagnostic Laboratories
- Physician Offices
Contact Our Analysts for Brochure Requests, Customization, or Any Pre-Purchase Inquiries: https://www.marknteladvisors.com/query/request-customization/infectious-respiratory-disease-diagnostics-market.html
Geographical Analysis
-By Region
- North America
- South America
- Europe
- Middle East & Africa
- Asia-Pacific
Based on the regions globally, Asia-Pacific is expected to attain a significant share of the Infectious Respiratory Disease Diagnostics Market during 2023-28.
Methodology Behind the Report
This research combines qualitative and quantitative methods, including:
- Expert interviews
- Proprietary forecasting models
- Financial and trade databases
- Government and institutional data
Forecasts are validated using top-down and bottom-up approaches to ensure accuracy and reliability.
Frequently Asked Questions About the Infectious Respiratory Disease Diagnostics Market
- What is the growth rate of the Infectious Respiratory Disease Diagnostics market from 2023–2028?
- Which segment are expected to dominate market?
- Who are the top companies and what strategies being they using?
- What are the key risks and challenges in this industry?
- How can businesses prepare for future trends?
About Us –
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
We have our existence across the market for many years and have conducted multi-industry research across 16.50+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.
Media Contact:
Company Name: MarkNtel Advisors
Email: sales@marknteladvisors.com
Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh - 201301, India
Comments